簡易檢索 / 詳目顯示

研究生: 陳信琮
Chen, Hsin-tsung
論文名稱: 納豆激酶之純化與活性分析之研究
Purification and Activity Characterization of Nattokinase
指導教授: 蕭世裕
Shaw, Shyh-Yu
學位類別: 碩士
Master
系所名稱: 理學院 - 化學系碩士在職專班
Department of Chemistry (on the job class)
論文出版年: 2008
畢業學年度: 96
語文別: 中文
論文頁數: 82
中文關鍵詞: 納豆納豆激酶血纖維蛋白
外文關鍵詞: Fibrin, Natto, Nattokinase
相關次數: 點閱:82下載:7
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 「納豆激酶」是一種絲胺酸型枯草桿菌類鹼性蛋白酶,主要是由微生物醱酵後所附在大豆表面的拉絲黏稠物質所組成,目前被廣泛應用於「保健食品」中。許多學者研究指出納豆激酶具有提高血漿中血纖維蛋白酶之水解活性,且可直接水解血纖維蛋白。

    本研究的主要目的為探討以液態醱酵培養方式所產生之納豆激酶及其功效評估。研究方法則有菌株之基本特性測試、不同納豆激酶劑量與血栓平板檢測準確度分析、利用快速蛋白質液相層析儀(FPLC,Fast Protein Liquid Chromatography)從納豆醱酵液中純化出納豆激酶及納豆激酶體外溶解血栓之動物測試(大白鼠口服),到最終的製作納豆激酶抗體(兔子)並利用蛋白質轉漬分析(western blot)等方式驗證該酵素是可以經腸、胃的吸收進入血液中。

    研究發現納豆菌之液態醱酵是以饋料培養方式優於一般批次培養方式,在比較其產生之納豆生菌數及激酶值方面,前者分別優於後者約3.95及2.9倍,而在大白鼠經口服納豆膠囊內容物後,發現在口服後第2小時可達最佳吸收效果,但是在8小時後降解。另外,其酵素動力學參數檢測值Km及Vmax則分別為0.926 mM及236 mM/hr。

    結論則是預防慢性病雖已成為國內外積極進行的重要研發項目,但其預防之道往往仍須藉由日常飲食與生活作息之改變開始,而將納豆菌醱酵食品(Natto fermented foods)融入日常飲食似乎是其中最簡易之預防方法之一;雖然研究發現納豆激酶可以作為預防血栓及其相關疾病之投遞藥物;但是,由於納豆激酶是屬於體外蛋白質,長期食用是否會對人體造成過敏等現象,仍需要進一步的確認。

    Nattokinase (NK) , a serine family subtilisin-like alkaline protease existing in the sticky cheese-like secreted by subtilis Natto on the surface of fermented soybean , has been widely applied to health-care food now. The enzyme has a high ability to degraded fibrin or activated plasminogen on the fibrinolytic system .

    In order to evaluate the physicochemical properties of the NK enzyme , liquid cultivation method and the transport mechanism of NK acrossing the rat intestinal tract into blood vessel have been explored and the experiments , such as enzyme activity test、the fibrin plate method for estimating fibrinolytic activity、purification of NK by FPLC from fermentation broth ﹑the parameters of enzyme kinetics measured by UV-vistable streptophotometer and detection of NK in the plasma from blood samples drawn at intervals after rat oral administration of the enzyme by Sodium dodecyl sulfate - Polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting analysis with an anti-NK antibody have been carried out .

    The results thus obtained suggested that production of the unit of NK activity and Natto bacteria count by liquid cultivation in fed-batch is better than batch culture. NK was absorbed from the rat intestinal tract and the highest absorption was ~2 hr after oral administration of the enzyme , and it was degraded after 8 hr . The parameters of enzyme kinetics measured showed that the Km=0.926 mM and Vmax is 236 mM/hr .

    Although NK is a potent fibrinolytic enzyme , which can be mass produced by liquid cultivation , it is also a potential drug for use in the treatment of embolism in the prevention of the disease. Nevertheless , it is still an extraneous protein , whether it will induce allergy in vivo is still under investigation .

    中文摘要…………………………………………………………Ⅰ 英文摘要………………………………………………………Ⅲ 目錄……………………………………………………………Ⅴ 表、圖目錄……………………………………………………Ⅸ 壹、前言………………………………………………………1 一、納豆簡介……………………………………………………1 二、納豆的成份與功效…………………………………………1 三、納豆激酶(nattokinase)之命名…………………………1 四、納豆激酶與心血管疾病……………………………………2 五、納豆激酶與健康食品……………………………………2 貳、文獻回顧…………………………………………………4 一、功效評估…………………………………………………4 二、Bacillus簡介………………………………………………4 參、材料與方法…………………………………………………6 一、實驗材料……………………………………………………6 二、實驗儀器……………………………………………………7 三、藥品配製…………………………………………………8 四、實驗方法…………………………………………………13 1.菌種的保存及活化…………………………………………13 2.液態培養納豆菌……………………………………………13 2.1一般批次醱酵培養……………………………………13 2.2饋料批次醱酵培養……………………………………14 2.3枯草桿菌屬混合培養…………………………………14 3.分析方法…………………………………………………14 3.1酵素活性測定…………………………………………14 3.2酵素活性計算…………………………………………15 4.納豆激酶之生理特性測試…………………………………15 4.1環境溫度對於納豆激酶之影響………………………15 4.2環境pH值對於納豆激酶之影響……………………16 4.3納豆激酶儲存之安定性……………………………16 5.納豆激酶及其功效評估……………………………………16 5.1人造血塊(fibrin clot)體外溶解試驗…………………16 5.2血塊(blood clot)體外溶解試驗………………………17 5.3不同納豆激酶劑量與血纖維蛋白平板(fibrin plate) 檢測準確度分析………………………………………17 5.4 酵素動力學參數檢測…………………………………18 6.從納豆醱酵液中純化出納豆激酶…………………………18 6.1硫酸銨鹽析沉澱法……………………………………19 6.2粗酵素溶液透析………………………………………19 6.3親和性層析管柱純化納豆激酶……………………19 7.十二烷基硫酸鈉聚丙烯醯胺膠體電泳(Sodium dodecyl sulfate–polyacrylamide gel electrophoresis,SDS–PAGE) 進行納豆激酶分子量分析………………………………20 8.動物試驗…………………………………………………….20 8.1大鼠(Rat) 經口服方式進行納豆激酶功效評估………20 8.2實驗流程…………………………………………………21 8.3 SDS–PAGE分析………………………………………21 9.以兔子(rabbit)製作納豆激酶抗體及蛋白質轉漬分析 (western blot)進行納豆激酶的確認……………………21 9.1製作納豆激酶抗體(創生)………………………………21 9.2蛋白質轉漬分析(western blot)……………………22 肆、結果………………………………………………………25 1.液態培養納豆菌……………………………………………25 1.1一般批次醱酵培養………………………………………25 1.2饋料批次醱酵培養……………………………………26 1.3枯草桿菌屬混合批次培養………………………………26 2.納豆激酶之生理特性測試…………………………………27 2.1環境溫度對於納豆激酶之影響…………………………27 2.2環境pH值對於納豆激酶之影響………………………27 2.3納豆激酶儲存之安定性………………………………27 2.4納豆菌數儲存之安定性……………………………28 3.納豆激酶及其功效評估……………………………………28 3.1人造血塊(fibrin clot)體外溶解試驗……………………28 3.2血塊(blood clot)體外溶解試驗………………………28 3.3不同納豆激酶劑量與血纖維蛋白平板(fibrin plate)檢測準 確度分………………………………………………29 3.4酵素動力學參數檢測…………………………………29 4.從納豆醱酵液中純化出納豆激酶……………………………30 4.1硫酸銨劃分………………………………………………30 4.2粗酵素溶液透析………………………………………30 4.3親和性層析管柱純化納豆激酶…………………………30 5.十二烷基硫酸鈉聚丙烯醯胺膠體電泳(sodium dodecyl sulfate–polyacrylamide gel electrophoresis,SDS–PAGE) 納 豆激酶分子量分析…………………………………………31 6.動物試驗……………………………………………………32 6.1大鼠(rat)經口服方式進行納豆激酶功效評估………32 6.2 SDS–PAGE分析……………………………………32 7.以兔子(rabbit)製作納豆激酶抗體…………………………32 8.蛋白質轉漬分析(western blot)…………………………33 伍、討論………………………………………………………34 陸、參考文獻…………………………………………………78

    1.于守洋,崔洪斌.新世紀保健食品全集.九州出版. 2003.
    2.蘇遠志.納豆菌代謝產物的開發與應用.生物產業. 14(2):117-130. 2003.
    3.呂易珍.液態納豆應用於化粧品之研究.靜宜大學應用化學研究所碩士論文. 2004.
    4.Sumi, H., Hamada, H., Tsushima, H., Mihara, H. and Muraki, H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto; a typical and popular soybean food in the Japanese diet. Experientia. 43:1110–1111. 1987.
    5.須見洋行,張偉喬.根除你的心血管慢性病.鼎樂出版. 2004.
    6.池仲芸.健康食品市場調查.財團法人生物技術開發中心. 1991.
    7.吳侑軒.液態黑納豆對於皮膚保健之研究.靜宜大學應用化學研究所碩士論文. 2004.
    8.Ohsugi, T., Ikeda, S. and Sumi, H. Anti-platelet Aggregation and Anti-blood Coagulation Activities of Dipicolinic Acid. FoodSci.Technol.Res. 11: 308-310. 2005.
    9.Okamoto, A., Hanagata, H., Kawamura, Y. and Yanagida, F. Anti-hypertensive substances in fermented soybean, natto. Plant Foods for Human Nutrition. 47:39-47. 1995.
    10.Pais, E., Alexy, T., Holsworth, R.E. and Meiselman, H.J. Effects of nattokinase, a pro-fibrinolytic enzyme, on red blood cell aggregation and whole blood viscosity. Clin.Hemorheol.Micro- circ. 35:139-142. 2006.
    11.Fujita, M., Ito Y, Hong K. and Nishimuro, S. Characterization of Nattokinase-degraded Products from Human Fibrinogen or Cross-linked Fibrin. Fibrinolysis. 9:157-164. 1995.
    12.Fujita, M., Hong, K., Ito, Y., Misawa, S., Takeuchi, N., Kariya, K. and Nishimuro, S. Transport of nattokinase across the rat intestinal tract. Biol Pharm Bull. 18,(9):1194-1196. 1995.
    13.Zheng, Z.L., Zou, G.L., Liu, Z.G., Tsai, K.C., Lie, A.F. and Zou, G.L. Construction of a 3D model of nattokinase,a novel fibrinolytic enzyme from Bacillus natto.A novel nucleophilic catalytic mechanism for nattokinase. J.Mol.Graph.Mod. 23:373. 2005.
    14.周儉.保健食品設計原理及其應用.九州出版. 2002.
    15.Fearnley, G.R., Balmforth, G. and Fearnley, E. Evidence of a diurnal fibrinolytic rhythm: With a simple method of measuring natural fibrinolysis. Clin.Sci. 16:645-650. 1957.
    16.Kim, S.D., Park, S.K., Cho, J.Y., Park, H.J., Lim, J.H., Yun, H.I., Park, S.C., Lee, K.Y., Kim, S.K. and Rhee, M.H. Surfactin C inhibits platelet aggregation. JPP 58(6):867-870. 2006.
    17.Milstone, H. A factor in normal human blood which participates in streptococcal fibrinolysis. J.Immun. 42:109-116. 1941.
    18.Sumi, H., Hamada, H., Nakanishi, K. and Hiratani, H. Enhancement of the fibrinolytic activity in plasma by oral administration of NattokinaseΙ. Acta Haematol. 84:139-43. 1990.
    19.劉璞.熱門保健食品全書.商周出版. 2004.
    20.林麗菁.納豆枯草菌之液態培養及其產生納豆激酶之探討.國立屏東科技大學食品科學研究所碩士論文. 2004.
    21.張碧芬,袁紹英,游呈祥.微生物學的世界.天下出版. 2004.
    22.Setlow, P. Spore germination. Current Opinion in Microbiology. 6:550-556. 2003.
    23.謝奉家.科學發展. 391:18-21. 2005.
    24.Katz, E. and Demain, A.L. The Peptide Antibiotics of Bacillus:Chemistry, Biogenesis, and Possible Functions. Bacteriological Reviews. 449-474. 1977.
    25.vanPutten, A.B., Spitzenberger, F., Kretzmer, G., Hitzmann, B. and Schugerl, K. On-line and off-line monitoring of the production of alkaline serine protease by Bacillus licheniformis. Analaly Chimica Acta. 371:247-258. 1995.
    26.vanPutten, A.B., Spitzenberger, F., Kretzmer, G., Hitzmann, B., Dors, M., Simutis, R. and Schugerl, K. lmprovement of the production of subtilisin Carlsberg alkaline protease by Bacillus licheniformis by on-line process monitoring and control in a stirred tank reactor. Journal of Biotechnology. 49:83-93. 1996.
    27.Wahome, P.G. and Setlow, P. The synthesis and role of the mechanosensitive channel of large conductance in growth and differentiation of Bacillus subtilis. Arch Microbiol. 186:377-383. 2006.
    28.Takano, A., Hirata, A., Ogasawara, K., Sagara, N., Inomata, Y., Kawaji, T. and Tanihara1, H. Posterior. Vitreous Detachment Induced by Nattokinase(Subtilisin NAT): A Novel Enzyme for Pharmacologic Vitreolysis. IOVS. 47(5):2075-2079. 2006.
    29.Astrup, T. and Mullertz, S. The fibrin plate method for estimating fibrinolytic activity. Arch.Biochem.Biophys. 40:346. 1952.
    30.Chohan I.S., Vermylen J.U., Singh I, Balakrishnan K. and Verstraete M. Sodium acetate buffer: A diluent of choice in the clot lysis time technique. Thromb.Diath.Haemorrh. 33:226-229. 1975.
    31.Carter, P. and Wells, J.A. Dissecting the catalytic triad of a serine protease. Nature(London). 332:564-568. 1988.
    32.Williams, K.M., Arthur, S.J., Burrell, G., Kelly, F., Phillips, D.W. and Marshall, T. An evaluation of protein assays for quantitative determination of drugs. Journal of Biochemical and Biophysical Methods. 57:45-55. 2003.
    33.Zheng, Z.L., Ye, M.Q., Zuo, Z.Y., Liu, Z.G., Tai, K.C. and Zou, G.L. Probing the importance of hydrogen bonds in the active site of the subtilisin Nattokinase by site-directed mutagenesis and molecular dynamics simulation. J.Biochem. 395:509. 2006.
    34.Fujita, M., Nomura, K., Hong, K., Ito, T., Asada, A. and Nishimuro, S. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese Natto, a popular soybean fermented food in Japan. Biochem. Biophys. Res. Commun. 197:1340-1347. 1993.
    35.徐惠玲.納豆菌Bacillus subtilis var.natto NPUST B11-2生產納豆激酶之最適培養條件及其生化特性探討.國立屏東科技大學食品科學研究所碩士論文. 2005.
    36.Deutscher, M. P. Guide to protein purification. Methods in Enzymology. 182:291. 1990.
    37.Nakamura, K., Suzuki, T., Hasegawa, M., Kato, Y., Sasaki, H. and Inouye, K. Characterization of p-aminobenzamidine - based sorbent and its use For high-performance affinity chromatography of trypsin-like proteases.Journal of Chromatography. 1009:133-139. 2003.
    38.Urano, T., Ihara, H., Umemura, K., Suzuki, Y., Oike, M., Akita, S., Tsukamoto, Y., Suzuki, I. and Takada, A. The profibrinolytic enzyme subtilisin NAT purified from Bacillus subtilis cleaves and inactivates plasminogen activator inhibitor.The Journal of Biology Chemical. 276(6):24690-24696. 2001.
    39.Yamashita, T., Oda, E. and Giddings, J.C. Yamamoto J. The Effect of Dietary Bacillus Natto Productive Protein on in vivo
    Endogenous Thrombolysis. Pathophysiol Haemost Thromb. 33:138-143. 2003.
    40.Suzuki, Y., Kondo, K., Matsumoto, Y., Zhao, B.Q., Otsuguro, K., Maeda, T., Tsukamoto, Y., Urano, T. and Umemura, K. Dietary supplementation of fermented soybean,natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Life Sciences. 73:1289-1298. 2003.
    41.http://www.medipoint.com/html/rats.
    42.Fichtel, J., Koster J., Scholz-Bottcher B., Sass H. and Rullkotter, J. A highly sensitive HPLC method for determination of nanomolar concentrations of dipicolinic acid,a characteristic constituent of bacterial endospores. Journal of Microbiological Methods. 70:319-327. 2007.

    下載圖示 校內:2013-08-25公開
    校外:2018-08-25公開
    QR CODE